Shanghai, July 6 (Reuters) - China stocks ended lower on Tuesday, with
healthcare and tech firms leading the losses, as local investors remained wary
of lofty valuations of certain sectors.
** The blue-chip CSI300 index edged down 0.1% to 5,083.10, while
the Shanghai Composite Index ended flat at 3,530.26 points.
** Shenzhen's start-up board declined 1.8%, while Shanghai's
tech-focused lost 2.7%.
** Leading the declines among sectors, the CSI300 healthcare index
tumbled as much as 6% before ending 3.8% lower.
** Hangzhou Tigermed Consulting Co Ltd, Shanghai Fosun
Pharmaceutical Group Co Ltd, Aier Eye Hospital Group Co Ltd
, Beijing Tongrentang Co Ltd, and Wuxi AppTec Co Ltd
retreated between 5% and 10.9%.
** "The growth rates of many healthcare firms could not support their
current high valuations," Yan Kaiwen, an analyst with China Fortune Securities
** Yan said some investors shifted to cheaper sectors with stable growth,
** The CSI300 real-estate index climbed 2.9%, with bellwether
Vanke up 2.8%.
** Around the region, MSCI's Asia ex-Japan stock index was
firmer by 0.08%, while Japan's Nikkei index closed up 0.16%.
** At 0713 GMT, the yuan was quoted at 6.4612 per U.S. dollar,
0.04% firmer than the previous close of 6.4639.
** As of 0714 GMT, China's A-shares were trading at a premium of 39.50% over
the Hong Kong-listed H-shares.
(Reporting by Shanghai Newsroom, Editing by Sherry Jacob-Phillips)